Literature DB >> 11892244

Biosafety issues in lentivector production.

C Delenda, M Audit, O Danos.   

Abstract

Mesh：

Year:  2002        PMID： 11892244     DOI： 10.1007/978-3-642-56114-6_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  3 in total

1.  Replication-competent lentivirus analysis of clinical grade vector products.

Authors:  Kenneth Cornetta; Jing Yao; Aparna Jasti; Sue Koop; Makhaila Douglas; David Hsu; Larry A Couture; Troy Hawkins; Lisa Duffy
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

Review 2.  Current and future alternative therapies for beta-thalassemia major.

Authors:  Edouard de Dreuzy; Kanit Bhukhai; Philippe Leboulch; Emmanuel Payen
Journal:  Biomed J       Date:  2016-04-06       Impact factor: 4.910

3.  The determination of importance of sequences neighboring the Psi sequence in lentiviral vector transduction and packaging efficiency.

Authors:  Seon Hee Kim; Hyun Jeong Jun; Soo In Jang; Ji Chang You
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.